Bionomics Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	Current	2023	2022	2021	2020
Market Capitalization	8	18	51	-	-
Market Cap Growth	-86.50%	-64.70%	-	-	-
Enterprise Value	-0	6	28	-21	5
PE Ratio	-	-0.82	-3.36	-	-
PS Ratio	560.73	1180.63	277.77	-	-
PB Ratio	0.43	0.79	1.29	-	-
P/FCF Ratio	-0.67	-1.22	-3.39	-	-
P/OCF Ratio	-0.67	-1.22	-3.37	-	-
EV/Sales Ratio	212.04	377.04	153.09	-	164.15
EV/EBITDA Ratio	-	-0.26	-1.84	3.77	-1.40
EV/EBIT Ratio	-0.15	-0.26	-1.84	3.77	-1.40
EV/FCF Ratio	-0.18	-0.39	-1.87	3.74	-2.10
Debt / Equity Ratio	0.05	0.02	0.01	0.02	0.96
Debt / EBITDA Ratio	-	-0.02	-0.03	-0.12	-2.23
Debt / FCF Ratio	-0.06	-0.02	-0.03	-0.12	-3.36
Quick Ratio	3.47	4.42	10.02	12.34	0.56
Current Ratio	3.81	4.87	12.46	13.10	1.01
Asset Turnover	0	0	0.00	0	-
Interest Coverage	-978.98	-1095.60	-496.03	-5.15	-2.97
Return on Equity (ROE)	-80.80%	-70.70%	-41.60%	-28.90%	-
Return on Assets (ROA)	-65.20%	-58.80%	-36.40%	-19.60%	-
Return on Capital (ROIC)	-0.74%	-96.80%	-47.10%	-26.87%	-48.43%
Earnings Yield	-250.82%	-122.35%	-29.71%	-	-
FCF Yield	-211.31%	-82.00%	-29.47%	-	-
Buyback Yield / Dilution	-14.43%	-12.16%	-0.80%	-	-
Total Shareholder Return	-14.43%	-12.16%	-0.80%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).